Biocartis Group NV (XBRU:BCART) Days Payable : 127.20 (As of Jun. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Biocartis Group NV Days Payable?

Biocartis Group NV's average Accounts Payable for the six months ended in Jun. 2023 was €9.32 Mil. Biocartis Group NV's Cost of Goods Sold for the six months ended in Jun. 2023 was €13.38 Mil. Hence, Biocartis Group NV's Days Payable for the six months ended in Jun. 2023 was 127.20.

The historical rank and industry rank for Biocartis Group NV's Days Payable or its related term are showing as below:

XBRU:BCART' s Days Payable Range Over the Past 10 Years
Min: 117.43 Med: 205.1 Max: 1330.24
Current: 117.43

During the past 11 years, Biocartis Group NV's highest Days Payable was 1330.24. The lowest was 117.43. And the median was 205.10.

XBRU:BCART's Days Payable is not ranked
in the Medical Diagnostics & Research industry.
Industry Median: 66.645 vs XBRU:BCART: 117.43

Biocartis Group NV's Days Payable declined from Jun. 2022 (141.95) to Jun. 2023 (127.20). It may suggest that Biocartis Group NV accelerated paying its suppliers.

Biocartis Group NV Days Payable Historical Data

The historical data trend for Biocartis Group NV's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biocartis Group NV Days Payable Chart

Biocartis Group NV Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Days Payable

Get a 7-Day Free Trial

160.85

145.83

159.54

137.01

142.74

Biocartis Group NV Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Days Payable	Get a 7-Day Free Trial															137.84	126.76	141.95	122.18	127.20

Competitive Comparison of Biocartis Group NV's Days Payable

For the Diagnostics & Research subindustry, Biocartis Group NV's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biocartis Group NV's Days Payable Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Biocartis Group NV's Days Payable distribution charts can be found below:

* The bar in red indicates where Biocartis Group NV's Days Payable falls into.

Biocartis Group NV Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Biocartis Group NV's Days Payable for the fiscal year that ended in Dec. 2022 is calculated as

	Days Payable (A: Dec. 2022 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2021 )	+	Accounts Payable (A: Dec. 2022 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2022 )	*	Days in Period
=	( (11.56	+	11.747)	/	2 )	/	29.799	*	365
=	11.6535					/	29.799	*	365
=	142.74

Biocartis Group NV's Days Payable for the quarter that ended in Jun. 2023 is calculated as:

	Days Payable (Q: Jun. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Dec. 2022 )	+	Accounts Payable (Q: Jun. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Jun. 2023 )	*	Days in Period
=	( (11.747	+	6.902)	/	2 )	/	13.378	*	365 / 2
=	9.3245					/	13.378	*	365 / 2
=	127.20

Biocartis Group NV Days Payable Related Terms

Thank you for viewing the detailed overview of Biocartis Group NV's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Biocartis Group NV (XBRU:BCART) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Biocartis Group NV (XBRU:BCART) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

Generaal de Wittelaan 11 B, Mechelen, BEL, 2800

Website

https://www.biocartis.com

Biocartis Group NV is a commercial-stage molecular diagnostics company. It provides diagnostic solutions aimed at improving clinical practice for patients, clinicians, payers, and the industry. The firm has developed an MDx Idylla molecular diagnostic system for oncology and infectious disease segments. Its products include EGFR mutation assay, BRAF mutation test, NRAS mutation test, respiratory panel, etc. The firm derives the majority of its revenues from product sales.

Biocartis Group NV (XBRU:BCART) Headlines

No Headlines